Search

everythinglearnresearchcommunity

for

Search:↓

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

Early hair loss may increase the risk of prostate cancer, especially in African American men and those with frontal baldness.

PSA might help diagnose PCOS and related skin issues, but more research is needed.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

Correct testosterone levels for age to treat prostate cancer, using low dose treatments as necessary.

Higher cholesterol levels increase aggressive prostate cancer risk.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Taking dutasteride for one month before prostate surgery can reduce bleeding.

Incidental prostate cancer was found in 4.89% of patients undergoing surgery for benign prostatic hyperplasia.

Gene variation affects prostate issues and hair loss.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Serum triglyceride levels are not linked to prostate cancer risk.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Low doses of BPA can increase prostate growth and change hormone levels in adult rats.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Taking finasteride before surgery reduces blood loss in prostate procedures.

Dutasteride and finasteride have similar effects on prostate cancer risk in BPH patients.

Low-dose finasteride and dutasteride reduce PSA levels by 27.8% in men with male androgenetic alopecia.

Kolaviron and quercetin may help treat prostate issues.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Thermobalancing Therapy can treat enlarged prostate and improve men's quality of life.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Finasteride may reduce prostate cancer spread by lowering certain enzyme levels.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

The normal human prostate does not significantly affect blood DHT levels.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Dutasteride may help shrink prostate cancer tumors.